TY - JOUR
T1 - Novel mouse mutants with primary cellular immunodeficiencies generated by genome-wide mutagenesis
AU - Jakob, Thilo
AU - Köllisch, Gabriele V.
AU - Howaldt, Maike
AU - Bewersdorff, Mayte
AU - Rathkolb, Birgit
AU - Müller, Marcel L.
AU - Sandholzer, Nadja
AU - Nitschke, Lars
AU - Schiemann, Matthias
AU - Mempel, Martin
AU - Ollert, Markus
AU - Neubauer, Antonie
AU - Soewarto, Dian A.
AU - Kremmer, Elisabeth
AU - Ring, Johannes
AU - Behrendt, Heidrun
AU - Flaswinkel, Heinrich
N1 - Funding Information:
Supported by grants from the German Federal Ministry of Science and Education (BMBF 01 KW 9924/8 to T.J. and H.B.) and from the German National Genome Project (UW-S15T03 to T.J., J.R., H.B., and M.O.).
PY - 2008/1
Y1 - 2008/1
N2 - Background: Primary cellular immunodeficiencies are a group of genetic disorders in which 1 or more components of the cellular immune system are lacking or dysfunctional. Objective: We sought to identify novel mouse mutants that display primary cellular immunodeficiencies. Methods: Genome-wide N-ethyl-N-nitrosourea mutagenesis was performed in mice, followed by a phenotype screen of immunologic blood parameters. Results: We identified novel mouse mutants with isolated B-cell deficiency, combined block in early B- and T-cell development, combined T-cell and natural killer cell reduction, and 3 different forms of T-cell deficiencies. One of the mutants, designated ΔT3, displayed a combined phenotype of increased IgE, absence of peripheral T cells, and block in late thymocyte differentiation. In addition, ΔT3 mice were unable to mount specific humoral immune responses. Chromosomal mapping and sequencing of candidate genes revealed a novel point mutation in the kinase domain of the T-cell receptor ζ chain-associated protein kinase (Zap70). In contrast to Zap70-deficient mice, ΔT3 mutants displayed normal Zap70 mRNA and residual Zap70 protein levels. Complementation studies with Zap70-deficient mice confirmed that the point mutation found in Zap70 was causative for the ΔT3 phenotype, including increased IgE plasma levels, a phenotype that has not been associated with altered Zap70 function in the past. Conclusion: Random genome-wide mutagenesis combined with a phenotype screen can be used to generate novel mouse mutants with primary cellular immunodeficiencies.
AB - Background: Primary cellular immunodeficiencies are a group of genetic disorders in which 1 or more components of the cellular immune system are lacking or dysfunctional. Objective: We sought to identify novel mouse mutants that display primary cellular immunodeficiencies. Methods: Genome-wide N-ethyl-N-nitrosourea mutagenesis was performed in mice, followed by a phenotype screen of immunologic blood parameters. Results: We identified novel mouse mutants with isolated B-cell deficiency, combined block in early B- and T-cell development, combined T-cell and natural killer cell reduction, and 3 different forms of T-cell deficiencies. One of the mutants, designated ΔT3, displayed a combined phenotype of increased IgE, absence of peripheral T cells, and block in late thymocyte differentiation. In addition, ΔT3 mice were unable to mount specific humoral immune responses. Chromosomal mapping and sequencing of candidate genes revealed a novel point mutation in the kinase domain of the T-cell receptor ζ chain-associated protein kinase (Zap70). In contrast to Zap70-deficient mice, ΔT3 mutants displayed normal Zap70 mRNA and residual Zap70 protein levels. Complementation studies with Zap70-deficient mice confirmed that the point mutation found in Zap70 was causative for the ΔT3 phenotype, including increased IgE plasma levels, a phenotype that has not been associated with altered Zap70 function in the past. Conclusion: Random genome-wide mutagenesis combined with a phenotype screen can be used to generate novel mouse mutants with primary cellular immunodeficiencies.
KW - IgE
KW - N-ethyl-N-nitrosourea mutagenesis
KW - Zap70
KW - immunodeficiency
KW - rodents
UR - http://www.scopus.com/inward/record.url?scp=38149123216&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2007.07.018
DO - 10.1016/j.jaci.2007.07.018
M3 - Article
C2 - 17767948
AN - SCOPUS:38149123216
SN - 0091-6749
VL - 121
SP - 179-184.e7
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 1
ER -